Infertility Tied to Poorer Cardiovascular Health in Women
11 Jan 2024
AHAClinical Study
THURSDAY, Jan. 11, 2024 -- A history of female infertility may serve as a marker for cardiovascular health (CVH) later in life, according to a study published online Jan. 5 in JAMA Network Open.
Amy R. Nichols, Ph.D., R.D., from Harvard University in Boston, and colleagues evaluated the association between infertility history with CVH at midlife (approximately age 50 years) among parous individuals. The analysis included 468 participants followed for approximately 18 years.
The researchers found that at midlife, the estimated overall American Heart Association Life’s Essential 8 score, a construct for ranking CVH in behavioral and biomedical domains, was 2.94 points lower, the biomedical score was 4.07 points lower, and the blood subdomain score was 5.98 points lower among those with versus without a history of infertility. There was also a trend toward a lower point estimate for the behavioral domain score (β = −1.81).
"This cohort study of parous individuals found evidence for an association between a history of infertility and lower overall and biomedical CVH scores," the authors write. "Our results provide additional weight to evidence suggesting inclusion of infertility history in assessing risk among female patients and demonstrate the importance of early identification and invocation of ongoing cardiovascular preventive strategies."
One author disclosed receiving personal fees from Modern Fertility for serving as a consultant on prenatal nutrition outside the submitted work.
Abstract/Full Text
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.